The influence of miR-34a expression on stemness and cytotoxic susceptibility of breast cancer stem cells

References

• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97; PMID:14744438; http://dx.doi.org/10.1016/S0092-8674(04)00045-5
   PubMed Web of Science ®Google Scholar
• DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA 2014; 64:52-62; PMID:24114568; http://dx.doi.org/10.1017/S0009840X1300228X
   PubMed Web of Science ®Google Scholar
• Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011; 17:211-5; PMID:21240262; http://dx.doi.org/10.1038/nm.2284
   PubMed Web of Science ®Google Scholar
• Bu P, Chen KY, Chen JH, Wang L, Walters J, Shin YJ, Goerger JP, Sun J, Witherspoon M, Rakhilin N, et al. A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell 2013; 12:602-15; PMID:23642368; http://dx.doi.org/10.1016/j.stem.2013.03.002
   PubMed Web of Science ®Google Scholar
• Ma W, Xiao GG, Mao J, Lu Y, Song B, Wang L, Fan S, Fan P, Hou Z, Li J, et al. Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness. Onco Target 2015; 6:10432-44
   Google Scholar
• Corney DC, Hwang CI, Matoso A, Vogt M, Flesken-Nikitin A, Godwin AK, Kamat AA, Sood AK, Ellenson LH, Hermeking H, et al. Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res 2010; 16:1119-28; PMID:20145172; http://dx.doi.org/10.1158/1078-0432.CCR-09-2642
   PubMed Web of Science ®Google Scholar
• Shi Y, Liu C, Liu X, Tang DG, Wang J. The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells. PloS One 2014; 9:e90022; PMID:24595209; http://dx.doi.org/10.1371/journal.pone.0090022
   PubMed Web of Science ®Google Scholar
• Rathod SS, Rani SB, Khan M, Muzumdar D, Shiras A. Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways. FEBS Open Bio 2014; 4:485-95; PMID:24944883; http://dx.doi.org/10.1016/j.fob.2014.05.002
   PubMed Web of Science ®Google Scholar
• Yang S, Li Y, Gao J, Zhang T, Li S, Luo A, Chen H, Ding F, Wang X, Liu Z. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene 2013; 32:4294-303; PMID:23001043; http://dx.doi.org/10.1038/onc.2012.432
   PubMed Web of Science ®Google Scholar
• Kang L, Mao J, Tao Y, Song B, Ma W, Lu Y, Zhao L, Li J, Yang B, Li L. MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway. Cancer Sci 2015; 106:700-8; PMID:25783790; http://dx.doi.org/10.1111/cas.12656
   PubMed Web of Science ®Google Scholar
• Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006; 107:2223-33; PMID:16291593; http://dx.doi.org/10.1182/blood-2005-08-3329
   PubMed Web of Science ®Google Scholar
• Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 2009; 69:7569-76; PMID:19773441; http://dx.doi.org/10.1158/0008-5472.CAN-09-0529
   PubMed Web of Science ®Google Scholar
• Babiarz JE, Blelloch R. Small RNAs - their biogenesis, regulation and function in embryonic stem cells. StemBook Cambridge MA: Harvard Stem Cell Institute, 2008.
   Google Scholar
• Peng GL, Tian Y, Lu C, Guo H, Zhao XW, Guo YW, Wang LQ, Du QL, Liu CP. Effects of Notch-1 down-regulation on malignant behaviors of breast cancer stem cells. J Huazhong University of Science and Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban 2014; 34:195-200; PMID:24710932; http://dx.doi.org/10.1007/s11596-014-1258-4
   PubMed Web of Science ®Google Scholar
• Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000; 1:119-26; PMID:11248803; http://dx.doi.org/10.1038/77793
   PubMed Web of Science ®Google Scholar
• Wang B, Wang Q, Wang Z, Jiang J, Yu SC, Ping YF, Yang J, Xu SL, Ye XZ, Xu C, et al. Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells. Cancer Res 2014; 74:5746-57; PMID:25164008; http://dx.doi.org/10.1158/0008-5472.CAN-13-2563
   PubMed Web of Science ®Google Scholar
• Fan X, Chen X, Deng W, Zhong G, Cai Q, Lin T. Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression. BMC Cancer 2013; 13:61; PMID:23383988; http://dx.doi.org/10.1186/1471-2407-13-61
   PubMed Web of Science ®Google Scholar
• Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005; 65:5506-11; PMID:15994920; http://dx.doi.org/10.1158/0008-5472.CAN-05-0626
   PubMed Web of Science ®Google Scholar
• Outtz HH, Wu JK, Wang X, Kitajewski J. Notch1 deficiency results in decreased inflammation during wound healing and regulates vascular endothelial growth factor receptor-1 and inflammatory cytokine expression in macrophages. J Immunol (Baltimore, Md : 1950) 2010; 185:4363-73; http://dx.doi.org/10.4049/jimmunol.1000720
   PubMed Web of Science ®Google Scholar
• Sell S. On the stem cell origin of cancer. Am J Pathol 2010; 176:2584-494; PMID:20431026; http://dx.doi.org/10.2353/ajpath.2010.091064
   PubMed Web of Science ®Google Scholar
• Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8:755-68; PMID:18784658; http://dx.doi.org/10.1038/nrc2499
   PubMed Web of Science ®Google Scholar
• Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007; 131:1109-23; PMID:18083101; http://dx.doi.org/10.1016/j.cell.2007.10.054
   PubMed Web of Science ®Google Scholar
• Melton C, Judson RL, Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 2010; 463:621-6; PMID:20054295; http://dx.doi.org/10.1038/nature08725
   PubMed Web of Science ®Google Scholar
• Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009; 138:592-603; PMID:19665978; http://dx.doi.org/10.1016/j.cell.2009.07.011
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-69; PMID:16557279; http://dx.doi.org/10.1038/nrc1840
   PubMed Web of Science ®Google Scholar
• Gerhardt DM, Pajcini KV, D'Altri T, Tu L, Jain R, Xu L, Chen MJ, Rentschler S, Shestova O, Wertheim GB, et al. The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells. Genes Dev 2014; 28:576-93; PMID:24637115; http://dx.doi.org/10.1101/gad.227496.113
   PubMed Web of Science ®Google Scholar
• Tian H, Biehs B, Chiu C, Siebel CW, Wu Y, Costa M, de Sauvage FJ, Klein OD. Opposing activities of Notch and Wnt signaling regulate intestinal stem cells and gut homeostasis. Cell Reports 2015; 11:33-42; PMID:25818302; http://dx.doi.org/10.1016/j.celrep.2015.03.007
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Murakami S, Yoneda T, Nakamura M, Zhang L, Uezumi A, Fukuda S, Kokubo H, Tsujikawa K, Fukada S. Evidence of Notch-Hesr-Nrf2 Axis in Muscle Stem Cells, but Absence of Nrf2 Has No Effect on Their Quiescent and Undifferentiated State. PloS One 2015; 10:e0138517; PMID:26418810; http://dx.doi.org/10.1371/journal.pone.0138517
   PubMedGoogle Scholar
• Yang GC, Xu YH, Chen HX, Wang XJ. Acute lymphoblastic leukemia cells inhibit the differentiation of bone mesenchymal stem cells into osteoblasts in vitro by activating notch signaling. Stem Cells Int 2015; 2015:162410; PMID:26339248
   PubMedGoogle Scholar
• Zhang C, Mo R, Yin B, Zhou L, Liu Y, Fan J. Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma. Oncol Letters 2014; 7:1689-94
   PubMed Web of Science ®Google Scholar
• Park EY, Chang E, Lee EJ, Lee HW, Kang HG, Chun KH, Woo YM, Kong HK, Ko JY, Suzuki H, et al. Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance. Cancer Res 2014; 74:7573-82; PMID:25368020; http://dx.doi.org/10.1158/0008-5472.CAN-14-1140
   PubMed Web of Science ®Google Scholar
• Liu C, Kelnar K, Vlassov AV, Brown D, Wang J, Tang DG. Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res 2012; 72:3393-404; PMID:22719071; http://dx.doi.org/10.1158/0008-5472.CAN-11-3864
   PubMed Web of Science ®Google Scholar
• Friese MA, Wischhusen J, Wick W, Weiler M, Eisele G, Steinle A, Weller M. RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res 2004; 64:7596-603; PMID:15492287; http://dx.doi.org/10.1158/0008-5472.CAN-04-1627
   PubMed Web of Science ®Google Scholar
• Cheng M, Chen Y, Xiao W, Sun R, Tian Z. NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol 2013; 10:230-52; PMID:23604045; http://dx.doi.org/10.1038/cmi.2013.10
   PubMed Web of Science ®Google Scholar
• Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 2010; 235:267-85; PMID:20536569; http://dx.doi.org/10.1111/j.0105-2896.2010.00893.x
   PubMed Web of Science ®Google Scholar
• Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000; 12:721-7; PMID:10894171; http://dx.doi.org/10.1016/S1074-7613(00)80222-8
   PubMed Web of Science ®Google Scholar
• Tokuyama M, Lorin C, Delebecque F, Jung H, Raulet DH, Coscoy L. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation. PLoS Pathogens 2011; 7:e1002265; PMID:21966273; http://dx.doi.org/10.1371/journal.ppat.1002265
   PubMedGoogle Scholar
• Park YP, Choi SC, Kiesler P, Gil-Krzewska A, Borrego F, Weck J, Krzewski K, Coligan JE. Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the gammac cytokines and TGF-beta1. Blood 2011; 118:3019-27; PMID:21816829; http://dx.doi.org/10.1182/blood-2011-04-346825
   PubMed Web of Science ®Google Scholar